• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α1肾上腺素能受体亚型选择性:分子建模与理论定量构效关系

Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships.

作者信息

De Benedetti P G, Fanelli F, Menziani M C, Cocchi M, Testa R, Leonardi A

机构信息

Dipartimento di Chimica, Università di Modena, Italy.

出版信息

Bioorg Med Chem. 1997 May;5(5):809-16. doi: 10.1016/s0968-0896(97)00007-2.

DOI:10.1016/s0968-0896(97)00007-2
PMID:9208092
Abstract

This study constitutes a preliminary rationalization, at the molecular level, of antagonist selectivity towards the three cloned alpha 1-adrenergic receptor (alpha 1-AR) subtypes. Molecular dynamics simulations allowed a structural/dynamics analysis of the seven alpha-helix-bundle models of the bovine alpha 1a-, hamster alpha 1b-, and rat alpha 1d-AR subtypes. The results showed that the transmembrane domains of these subtypes have different dynamic behaviours and different topographies of the binding sites, which are mainly constituted by conserved residues. In particular, the alpha 1a-AR binding site is more flexible and topographically different with respect to the other two subtypes. The results of the theoretical structural/dynamics analysis of the isolated receptors are consistent with the binding affinities of the 16 antagonists tested towards the three cloned alpha 1-AR subtypes. Moreover, the theoretical quantitative structure-affinity relationships obtained from the antagonist-receptor interaction models further corroborates the hypothesis that selectivity towards one preferential subtype is mainly modulated by receptor and/or ligand distortion energies. In other words, subtype selectivity seems to be mainly guided by the dynamic complementarity (induced fit) between ligand and receptor. On the basis of the quantitative models presented it is possible to predict both affinities and selectivities of putative alpha 1-AR ligands as well as to estimate the theoretical alpha 1-AR subtype affinities and selectivities of existing antagonists.

摘要

本研究在分子水平上对拮抗剂针对三种克隆的α1 - 肾上腺素能受体(α1 - AR)亚型的选择性进行了初步合理化分析。分子动力学模拟对牛α1a -、仓鼠α1b - 和大鼠α1d - AR亚型的七个α - 螺旋束模型进行了结构/动力学分析。结果表明,这些亚型的跨膜结构域具有不同的动力学行为和不同的结合位点拓扑结构,这些位点主要由保守残基组成。特别是,α1a - AR结合位点相对于其他两种亚型更具灵活性且拓扑结构不同。对分离受体进行的理论结构/动力学分析结果与所测试的16种拮抗剂对三种克隆α1 - AR亚型的结合亲和力一致。此外,从拮抗剂 - 受体相互作用模型获得的理论定量结构 - 亲和力关系进一步证实了以下假设:对一种优先亚型的选择性主要由受体和/或配体的畸变能调节。换句话说,亚型选择性似乎主要由配体与受体之间的动态互补性(诱导契合)所引导。基于所提出的定量模型,可以预测推定的α1 - AR配体的亲和力和选择性,以及估计现有拮抗剂的理论α1 - AR亚型亲和力和选择性。

相似文献

1
Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships.α1肾上腺素能受体亚型选择性:分子建模与理论定量构效关系
Bioorg Med Chem. 1997 May;5(5):809-16. doi: 10.1016/s0968-0896(97)00007-2.
2
Identification of critical extracellular loop residues involved in alpha 1-adrenergic receptor subtype-selective antagonist binding.参与α1-肾上腺素能受体亚型选择性拮抗剂结合的关键细胞外环残基的鉴定。
Mol Pharmacol. 1996 Nov;50(5):1118-26.
3
Synthesis, screening, and molecular modeling of new potent and selective antagonists at the alpha 1d adrenergic receptor.α1d肾上腺素能受体新型强效选择性拮抗剂的合成、筛选及分子模拟
J Med Chem. 2004 Apr 8;47(8):1900-18. doi: 10.1021/jm030944+.
4
Identification of critical determinants of alpha 1-adrenergic receptor subtype selective agonist binding.α1-肾上腺素能受体亚型选择性激动剂结合关键决定因素的鉴定
J Biol Chem. 1995 Sep 29;270(39):23189-95. doi: 10.1074/jbc.270.39.23189.
5
Amino acids of the human alpha1d-adrenergic receptor involved in antagonist binding.
J Pharmacol Sci. 2008 Jan;106(1):114-20. doi: 10.1254/jphs.fp0071412. Epub 2008 Jan 11.
6
KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.KMD-3213,一种新型、强效、α1a肾上腺素能受体选择性拮抗剂:利用重组人α1肾上腺素能受体和天然组织进行的特性研究
Mol Pharmacol. 1995 Aug;48(2):250-8.
7
New pyrimido[5,4-b]indoles as ligands for alpha(1)-adrenoceptor subtypes.新型嘧啶并[5,4-b]吲哚作为α(1)-肾上腺素能受体亚型的配体。
J Med Chem. 2003 Jul 3;46(14):2877-94. doi: 10.1021/jm0307741.
8
Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.新型芳基哌嗪模型的合成与构效关系。通过经典汉施分析、人工神经网络以及配体识别的计算模拟研究5-羟色胺(1a)/α(1)-肾上腺素能受体亲和力。
J Med Chem. 2001 Jan 18;44(2):198-207. doi: 10.1021/jm000930t.
9
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.咪唑啉α-肾上腺素能受体激动剂(羟甲唑啉和西拉唑啉)对人克隆α1-肾上腺素能受体亚型的选择性。
Br J Pharmacol. 1995 Sep;116(1):1611-8. doi: 10.1111/j.1476-5381.1995.tb16381.x.
10
Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.克隆的α1A/D-肾上腺素能受体亚型的药理学特性与在大鼠大脑皮层和输精管中鉴定出的α1A-肾上腺素能受体一致。
Br J Pharmacol. 1994 Apr;111(4):1003-8. doi: 10.1111/j.1476-5381.1994.tb14843.x.

引用本文的文献

1
Quantitative structure-activity relationships of alpha1 adrenergic antagonists.α1肾上腺素能拮抗剂的定量构效关系
J Mol Model. 2004 Apr;10(2):139-50. doi: 10.1007/s00894-003-0177-2. Epub 2004 Mar 3.